Azido-3′-deoxythymidine(AZT) was the first clinically approved drug against HIV infection, despite its undesirable side reactions, such as bone marrow suppression. In our aim to develop new chemical entity of anti-tu...Azido-3′-deoxythymidine(AZT) was the first clinically approved drug against HIV infection, despite its undesirable side reactions, such as bone marrow suppression. In our aim to develop new chemical entity of anti-tumor and anti-HIV, the H-phosphonate 6 of AZT conjugate with diosgenin was synthesized by a tandem transesterification reaction for the first time. There are the merits of easy operation and high yield in the reported method. It could be extended to synthesize other diosgenin phosphonate conjugates such as carbohydrate and peptide.展开更多
3'-磷酸腺苷-5'-磷酰硫酸(PAPS)是生物肝素酶法制备途径的硫磺基供体,价格高且易分解。芳基硫磺基转移酶(ASTIV,EC 2.8.2.1)可以转化对硝基硫酸苯酯(PNPS)和3'-磷酸腺苷-5'-磷酸(PAP)生成PAPS。利用大肠杆菌系统高效可...3'-磷酸腺苷-5'-磷酰硫酸(PAPS)是生物肝素酶法制备途径的硫磺基供体,价格高且易分解。芳基硫磺基转移酶(ASTIV,EC 2.8.2.1)可以转化对硝基硫酸苯酯(PNPS)和3'-磷酸腺苷-5'-磷酸(PAP)生成PAPS。利用大肠杆菌系统高效可溶性表达ASTIV。对鼠源ASTIV基因序列进行密码子优化并全合成;转入大肠杆菌BL21(DE3)中诱导表达;对表达条件进行优化,提高可溶表达量;Ni2+亲和层析纯化目标蛋白,重组ASTIV产量达到80 mg/L,纯度高达95.3%,比酶活为42.5 m U/mg;用碱性磷酸酶(CIAP)转化ASTIV构型,比酶活进一步提高到85.0 m U/mg。该研究为ASTIV重组表达,PAPS酶法制备以及生物肝素合成奠定了坚实的基础。展开更多
文摘Azido-3′-deoxythymidine(AZT) was the first clinically approved drug against HIV infection, despite its undesirable side reactions, such as bone marrow suppression. In our aim to develop new chemical entity of anti-tumor and anti-HIV, the H-phosphonate 6 of AZT conjugate with diosgenin was synthesized by a tandem transesterification reaction for the first time. There are the merits of easy operation and high yield in the reported method. It could be extended to synthesize other diosgenin phosphonate conjugates such as carbohydrate and peptide.
文摘3'-磷酸腺苷-5'-磷酰硫酸(PAPS)是生物肝素酶法制备途径的硫磺基供体,价格高且易分解。芳基硫磺基转移酶(ASTIV,EC 2.8.2.1)可以转化对硝基硫酸苯酯(PNPS)和3'-磷酸腺苷-5'-磷酸(PAP)生成PAPS。利用大肠杆菌系统高效可溶性表达ASTIV。对鼠源ASTIV基因序列进行密码子优化并全合成;转入大肠杆菌BL21(DE3)中诱导表达;对表达条件进行优化,提高可溶表达量;Ni2+亲和层析纯化目标蛋白,重组ASTIV产量达到80 mg/L,纯度高达95.3%,比酶活为42.5 m U/mg;用碱性磷酸酶(CIAP)转化ASTIV构型,比酶活进一步提高到85.0 m U/mg。该研究为ASTIV重组表达,PAPS酶法制备以及生物肝素合成奠定了坚实的基础。